17 June 2014, London
This seminar will bring together policymakers with key industry stakeholders to discuss what more can be done to support innovation, skills and growth across UK health life sciences. It is scheduled to assess latest measures being undertaken by Government as part of its ongoing Strategy for UK Life Sciences, and will bring out latest thinking on the next steps for effective industrial strategy in this sector.
Alongside key policymakers, sessions will bring together representatives from pharmaceuticals, bio and medical technology industries, as well as universities, NHS partnerships, investors and commentators. Delegates will have particular opportunity to consider the next steps for developing an effective life sciences ecosystem, what more can be done to attract talent to the sector, and latest initiatives being undertaken to tackle barriers to investment and innovation.
Guests of Honour: Mark Samuels, Managing Director, NIHR Office for Clinical Research Infrastructure and Dr Mark Treherne, Chief Executive, Life Science Investment Organisation, UK Trade & Investment,